Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

104 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France.
Million M, Lagier JC, Gautret P, Colson P, Fournier PE, Amrane S, Hocquart M, Mailhe M, Esteves-Vieira V, Doudier B, Aubry C, Correard F, Giraud-Gatineau A, Roussel Y, Berenger C, Cassir N, Seng P, Zandotti C, Dhiver C, Ravaux I, Tomei C, Eldin C, Tissot-Dupont H, Honoré S, Stein A, Jacquier A, Deharo JC, Chabrière E, Levasseur A, Fenollar F, Rolain JM, Obadia Y, Brouqui P, Drancourt M, La Scola B, Parola P, Raoult D. Million M, et al. Among authors: dhiver c. Travel Med Infect Dis. 2020 May-Jun;35:101738. doi: 10.1016/j.tmaid.2020.101738. Epub 2020 May 5. Travel Med Infect Dis. 2020. PMID: 32387409 Free PMC article.
Antiretroviral therapy does not block the secretion of the human immunodeficiency virus tat protein.
Mediouni S, Darque A, Baillat G, Ravaux I, Dhiver C, Tissot-Dupont H, Mokhtari M, Moreau H, Tamalet C, Brunet C, Paul P, Dignat-George F, Stein A, Brouqui P, Spector SA, Campbell GR, Loret EP. Mediouni S, et al. Among authors: dhiver c. Infect Disord Drug Targets. 2012 Feb;12(1):81-6. doi: 10.2174/187152612798994939. Infect Disord Drug Targets. 2012. PMID: 22280310
Hepatitis C virus NS3 protease genotyping and drug concentration determination during triple therapy with telaprevir or boceprevir for chronic infection with genotype 1 viruses, southeastern France.
Aherfi S, Solas C, Motte A, Moreau J, Borentain P, Mokhtari S, Botta-Fridlund D, Dhiver C, Portal I, Ruiz JM, Ravaux I, Bregigeon S, Poizot-Martin I, Stein A, Gérolami R, Brouqui P, Tamalet C, Colson P. Aherfi S, et al. Among authors: dhiver c. J Med Virol. 2014 Nov;86(11):1868-76. doi: 10.1002/jmv.24016. Epub 2014 Jul 23. J Med Virol. 2014. PMID: 25052594
Dolutegravir and weight gain: an unexpected bothering side effect?
Menard A, Meddeb L, Tissot-Dupont H, Ravaux I, Dhiver C, Mokhtari S, Tomei C, Brouqui P, Colson P, Stein A. Menard A, et al. Among authors: dhiver c. AIDS. 2017 Jun 19;31(10):1499-1500. doi: 10.1097/QAD.0000000000001495. AIDS. 2017. PMID: 28574967 No abstract available.
Emergence of uncommon HIV-1 non-B subtypes and circulating recombinant forms and trends in transmission of antiretroviral drug resistance in patients with primary infection during the 2013-2015 period in Marseille, Southeastern France.
Tamalet C, Tissot-Dupont H, Motte A, Tourrès C, Dhiver C, Ravaux I, Poizot-Martin I, Dieng T, Tomei C, Bregigeon S, Zaegel-Faucher O, Laroche H, Aherfi S, Mokhtari S, Chaudet H, Ménard A, Brouqui P, Stein A, Colson P. Tamalet C, et al. Among authors: dhiver c. J Med Virol. 2018 Oct;90(10):1559-1567. doi: 10.1002/jmv.25228. Epub 2018 Jun 11. J Med Virol. 2018. PMID: 29797570
Multimorbidity in Elderly Persons According to the Year of Diagnosis of Human Immunodeficiency Virus Infection: A Cross-sectional Dat'AIDS Cohort Study.
Demontès M, Eymard Duvernay S, Allavena C, Jovelin T, Reynes J, Hentzien M, Ravaux I, Delobel P, Bregigeon S, Rey D, Ferry T, Gagneux-Brunon A, Robineau O, Pugliese P, Duvivier C, Cabié A, Chirouze C, Jacomet C, Lamaury I, Merrien D, Hoen B, Hocqueloux L, Cheret A, Katlama C, Arvieux C, Krolak-Salmon P, Makinson A; Dat’AIDS Study Group. Demontès M, et al. Clin Infect Dis. 2020 Dec 31;71(11):2880-2888. doi: 10.1093/cid/ciz1171. Clin Infect Dis. 2020. PMID: 31813982
Kaposi sarcoma among people living with HIV in the French DAT'AIDS cohort between 2010 and 2015.
Poizot-Martin I, Obry-Roguet V, Duvivier C, Lions C, Huleux T, Jacomet C, Ferry T, Cheret A, Allavena C, Bani-Sadr F, Palich R, Cabié A, Fresard A, Pugliese P, Delobel P, Lamaury I, Hustache-Mathieu L, Brégigeon S, Makinson A, Rey D; Dat'AIDS study group. Poizot-Martin I, et al. J Eur Acad Dermatol Venereol. 2020 May;34(5):1065-1073. doi: 10.1111/jdv.16204. Epub 2020 Apr 30. J Eur Acad Dermatol Venereol. 2020. PMID: 31953902 Free PMC article.
Early combination therapy with hydroxychloroquine and azithromycin reduces mortality in 10,429 COVID-19 outpatients.
Million M, Lagier JC, Tissot-Dupont H, Ravaux I, Dhiver C, Tomei C, Cassir N, Delorme L, Cortaredona S, Amrane S, Aubry C, Bendamardji K, Berenger C, Doudier B, Edouard S, Hocquart M, Mailhe M, Porcheto C, Seng P, Triquet C, Gentile S, Jouve E, Giraud-Gatineau A, Chaudet H, Camoin-Jau L, Colson P, Gautret P, Fournier PE, Maille B, Deharo JC, Habert P, Gaubert JY, Jacquier A, Honore S, Guillon-Lorvellec K, Obadia Y, Parola P, Brouqui P, Raoult D. Million M, et al. Among authors: dhiver c. Rev Cardiovasc Med. 2021 Sep 24;22(3):1063-1072. doi: 10.31083/j.rcm2203116. Rev Cardiovasc Med. 2021. PMID: 34565108 Free article.
No increased risk of Kaposi sarcoma relapse in patients with controlled HIV-1 infection after switching protease inhibitor-based antiretroviral therapy.
Lajaunie R, Cuzin L, Palich R, Makinson A, Bani-Sadr F, Duvivier C, Arvieux C, Rey D, Poizot-Martin I, Delpierre C, Delobel P, Martin-Blondel G; And The Dat’AIDS study group. Lajaunie R, et al. HIV Med. 2022 Mar;23(3):301-306. doi: 10.1111/hiv.13168. Epub 2021 Oct 19. HIV Med. 2022. PMID: 34668293 Free article.
Multidrug resistance genotypes (insertions in the beta3-beta4 finger subdomain and MDR mutations) of HIV-1 reverse transcriptase from extensively treated patients: incidence and association with other resistance mutations.
Tamalet C, Yahi N, Tourrès C, Colson P, Quinson AM, Poizot-Martin I, Dhiver C, Fantini J. Tamalet C, et al. Among authors: dhiver c. Virology. 2000 May 10;270(2):310-6. doi: 10.1006/viro.2000.0261. Virology. 2000. PMID: 10792990 Free article.
Population pharmacokinetics of Rilpivirine in HIV-1-infected patients treated with the single-tablet regimen rilpivirine/tenofovir/emtricitabine.
Néant N, Gattacceca F, Lê MP, Yazdanpanah Y, Dhiver C, Bregigeon S, Mokhtari S, Peytavin G, Tamalet C, Descamps D, Lacarelle B, Solas C. Néant N, et al. Among authors: dhiver c. Eur J Clin Pharmacol. 2018 Apr;74(4):473-481. doi: 10.1007/s00228-017-2405-1. Epub 2018 Jan 26. Eur J Clin Pharmacol. 2018. PMID: 29374296
Usefulness of therapeutic drug monitoring of rilpivirine and its relationship with virologic response and resistance in a cohort of naive and pretreated HIV-infected patients.
Néant N, Lê MP, Bouazza N, Gattacceca F, Yazdanpanah Y, Dhiver C, Bregigeon S, Mokhtari S, Peytavin G, Tamalet C, Descamps D, Lacarelle B, Solas C. Néant N, et al. Among authors: dhiver c. Br J Clin Pharmacol. 2020 Dec;86(12):2404-2413. doi: 10.1111/bcp.14344. Epub 2020 Jun 1. Br J Clin Pharmacol. 2020. PMID: 32374049 Free PMC article.
[Drug addiction and HIV-1/HTLV-2 co-infection in Marseille].
Vignoli C, Tamalet C, Zandotti C, De Lamballerie X, Dhiver C, Gastaut JA, De Micco P. Vignoli C, et al. Among authors: dhiver c. Presse Med. 1992 Oct 24;21(35):1686. Presse Med. 1992. PMID: 1480572 French. No abstract available.
Dolutegravir-based dual maintenance regimens combined with lamivudine/emtricitabine or rilpivirine: risk of virological failure in a real-life setting.
Deschanvres C, Reynes J, Lamaury I, Rey D, Palich R, Bani-Sadr F, Robineau O, Duvivier C, Hocqueloux L, Cuzin L, Joly V, Raffi F, Cabie A, Allavena C; Dat’AIDS Study Group. Deschanvres C, et al. J Antimicrob Chemother. 2021 Dec 24;77(1):196-204. doi: 10.1093/jac/dkab367. J Antimicrob Chemother. 2021. PMID: 34651192
Boosted lopinavir- versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: a prospective study of HIV-infected individuals in high-income countries.
HIV-CAUSAL Collaboration; Cain LE, Phillips A, Olson A, Sabin C, Jose S, Justice A, Tate J, Logan R, Robins JM, Sterne JA, van Sighem A, Reiss P, Young J, Fehr J, Touloumi G, Paparizos V, Esteve A, Casabona J, Monge S, Moreno S, Seng R, Meyer L, Pérez-Hoyos S, Muga R, Dabis F, Vandenhende MA, Abgrall S, Costagliola D, Hernán MA. HIV-CAUSAL Collaboration, et al. Clin Infect Dis. 2015 Apr 15;60(8):1262-8. doi: 10.1093/cid/ciu1167. Epub 2015 Jan 6. Clin Infect Dis. 2015. PMID: 25567330 Free PMC article.
[Kaposi's sarcoma in AIDS. 70 cases].
Lafeuillade A, Poizot-Martin I, Dhiver C, Giovannini M, Viallat JR, Quilichini R, Bouabdallah R, Gastaut JA. Lafeuillade A, et al. Among authors: dhiver c. Presse Med. 1991 Jan 26;20(3):113-6. Presse Med. 1991. PMID: 1705701 French.
The effect of efavirenz versus nevirapine-containing regimens on immunologic, virologic and clinical outcomes in a prospective observational study.
Cain LE, Phillips A, Lodi S, Sabin C, Bansi L, Justice A, Tate J, Logan R, Robins JM, Sterne JA, van Sighem A, de Wolf F, Bucher HC, Elzi L, Touloumi G, Vourli G, Esteve A, Casabona J, del Amo J, Moreno S, Seng R, Meyer L, Pérez-Hoyos S, Muga R, Abgrall S, Costagliola D, Hernán MA; HIV-CAUSAL Collaboration. Cain LE, et al. AIDS. 2012 Aug 24;26(13):1691-705. doi: 10.1097/QAD.0b013e328354f497. AIDS. 2012. PMID: 22546987 Free PMC article.
[Acquired hypertrichosis of eyelashes in AIDS].
Poizot-Martin I, Lafeuillade A, Gourgeonnet A, Dhiver C, Gamby T, Gastaut JA. Poizot-Martin I, et al. Among authors: dhiver c. Ann Dermatol Venereol. 1992;119(2):143-4. Ann Dermatol Venereol. 1992. PMID: 1605514 French. No abstract available.
Are CD4 antibodies and peptide T new treatments for psoriasis?
Poizot-Martin I, Dhiver C, Mawas C, Olive D, Gastaut JA. Poizot-Martin I, et al. Among authors: dhiver c. Lancet. 1991 Jun 15;337(8755):1477. doi: 10.1016/0140-6736(91)93166-7. Lancet. 1991. PMID: 1675339 No abstract available.
Protein S deficiency and HIV infection.
Lafeuillade A, Alessi MC, Poizot-Martin I, Dhiver C, Quilichini R, Aubert L, Gastaut JA, Juhan-Vague I. Lafeuillade A, et al. Among authors: dhiver c. N Engl J Med. 1991 Apr 25;324(17):1220. doi: 10.1056/NEJM199104253241718. N Engl J Med. 1991. PMID: 1826342 No abstract available.
[Cutaneo-mucosal hyperpigmentation in AIDS. 4 cases].
Poizot-Martin I, Lafeuillade A, Dhiver C, Xeri L, Bouabdallah R, Gamby T, Gastaut JA. Poizot-Martin I, et al. Among authors: dhiver c. Presse Med. 1991 Apr 13;20(14):632-6. Presse Med. 1991. PMID: 1828567 Review. French.
[Mollusca contagiosa-like cutaneous cryptococcosis in AIDS: a case].
Poizot-Martin I, Grob JJ, Fournerie JR, Dhiver C, Andrac L, Gastaut JA, Bonerandi JJ. Poizot-Martin I, et al. Among authors: dhiver c. Ann Dermatol Venereol. 1991;118(1):29-32. Ann Dermatol Venereol. 1991. PMID: 2018303 Review. French. No abstract available.
Zidovudine overdose: a case with bone-marrow toxicity.
Lafeuillade A, Poizot-Martin I, Dhiver C, Bouabdallah R, Quilichini R, Gastaut JA. Lafeuillade A, et al. Among authors: dhiver c. AIDS. 1991 Jan;5(1):116-7. AIDS. 1991. PMID: 2059355 No abstract available.
Porphyria cutanea tarda associated with HIV infection.
Lafeuillade A, Dhiver C, Martin I, Quilichini R, Gastaut JA. Lafeuillade A, et al. Among authors: dhiver c. AIDS. 1990 Sep;4(9):924. doi: 10.1097/00002030-199009000-00017. AIDS. 1990. PMID: 2252568 Review. No abstract available.
Cellular and plasma viral load in patients infected with HIV-2.
Simon F, Matheron S, Tamalet C, Loussert-Ajaka I, Bartczak S, Pépin JM, Dhiver C, Gamba E, Elbim C, Gastaut JA, et al. Simon F, et al. Among authors: dhiver c. AIDS. 1993 Nov;7(11):1411-7. doi: 10.1097/00002030-199311000-00002. AIDS. 1993. PMID: 7904166
[Colonic leishmaniasis in AIDS].
Duval JL, Jaubert D, Poizot-Martin I, De Jaureguiberry JP, Lafeuillade A, Giovannini M, Carloz E, Dhiver C, Gastaut JA. Duval JL, et al. Among authors: dhiver c. Ann Med Interne (Paris). 1994;145(3):198-9. Ann Med Interne (Paris). 1994. PMID: 8092638 French. No abstract available.
The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals.
HIV-CAUSAL Collaboration; Ray M, Logan R, Sterne JA, Hernández-Díaz S, Robins JM, Sabin C, Bansi L, van Sighem A, de Wolf F, Costagliola D, Lanoy E, Bucher HC, von Wyl V, Esteve A, Casbona J, del Amo J, Moreno S, Justice A, Goulet J, Lodi S, Phillips A, Seng R, Meyer L, Pérez-Hoyos S, García de Olalla P, Hernán MA. HIV-CAUSAL Collaboration, et al. AIDS. 2010 Jan 2;24(1):123-37. doi: 10.1097/QAD.0b013e3283324283. AIDS. 2010. PMID: 19770621 Free PMC article.
Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries.
del Amo J, Moreno S, Bucher HC, Furrer H, Logan R, Sterne J, Pérez-Hoyos S, Jarrín I, Phillips A, Lodi S, van Sighem A, de Wolf W, Sabin C, Bansi L, Justice A, Goulet J, Miró JM, Ferrer E, Meyer L, Seng R, Toulomi G, Gargalianos P, Costagliola D, Abgrall S, Hernán MA; HIV-CAUSAL Collaboration. del Amo J, et al. Clin Infect Dis. 2012 May;54(9):1364-72. doi: 10.1093/cid/cis203. Epub 2012 Mar 28. Clin Infect Dis. 2012. PMID: 22460971 Free PMC article.
Pharmacokinetic interaction between maraviroc and etravirine in HIV-infected patients receiving regimens containing both drugs and no ritonavir-boosted protease inhibitor.
Lê MP, Solas C, Garraffo R, Gagnieu MC, Muret P, Yeni P, Dhiver C, Katlama C, Poizot-Martin I, Durant J, Peytavin G. Lê MP, et al. Among authors: dhiver c. J Antimicrob Chemother. 2012 Nov;67(11):2779-81. doi: 10.1093/jac/dks260. Epub 2012 Jul 6. J Antimicrob Chemother. 2012. PMID: 22773742 No abstract available.
Real-World Efficacy of Daclatasvir and Sofosbuvir, With and Without Ribavirin, in HIV/HCV Coinfected Patients With Advanced Liver Disease in a French Early Access Cohort.
Lacombe K, Fontaine H, Dhiver C, Metivier S, Rosenthal E, Antonini T, Valantin MA, Miailhes P, Harent S, Batisse D, Pageaux GP, Chas J, Aumaitre H, Dominguez S, Allegre T, Lafeuillade A, Billaud E, De Truchis P, Perre P, Leroy V, De Ledinghen V, Sogni P, Dabis F, Zhao Y, Filipovics A, Fedchuk L, Akremi R, Bennai Y, Salmon Ceron D. Lacombe K, et al. Among authors: dhiver c. J Acquir Immune Defic Syndr. 2017 May 1;75(1):97-107. doi: 10.1097/QAI.0000000000001342. J Acquir Immune Defic Syndr. 2017. PMID: 28272163 Free PMC article.
[Hemichorea-hemiballismus and toxoplasmosis in AIDS].
Gastaut JL, Nicoli F, Somma-Mauvais H, Bartolomei F, Dalecky A, Bruzzo M, Dhiver C, Gastaut JA. Gastaut JL, et al. Among authors: dhiver c. Rev Neurol (Paris). 1992;148(12):785-8. Rev Neurol (Paris). 1992. PMID: 1303576 French.
[Epilepsy seizures in HIV infection. 52 cases].
Bartolomei F, Pellegrino P, Dhiver C, Quilichini R, Gastaut JA, Gastaut JL. Bartolomei F, et al. Among authors: dhiver c. Presse Med. 1991 Dec 7;20(42):2135-8. Presse Med. 1991. PMID: 1837361 Review. French.
[Multicentric bone chloroma disclosed by pleural cytology].
Robaglia A, Horschowski N, Sainty D, Xerri L, Guitard AM, Gastaut JA, Dhiver C, Seite R. Robaglia A, et al. Among authors: dhiver c. Arch Anat Cytol Pathol. 1990;38(1-2):19-21. Arch Anat Cytol Pathol. 1990. PMID: 2188617 Review. French.
Intestinal spirochaetosis in HIV infected homosexual men.
Lafeuillade A, Quilichini R, Benderitter T, Delbeke E, Dhiver C, Gastaut JA. Lafeuillade A, et al. Among authors: dhiver c. Postgrad Med J. 1990 Mar;66(773):253-4. doi: 10.1136/pgmj.66.773.253-a. Postgrad Med J. 1990. PMID: 2362901 Free PMC article. No abstract available.
A multicenter proton magnetic resonance spectroscopy study of neurological complications of AIDS.
Paley M, Cozzone PJ, Alonso J, Vion-Dury J, Confort-Gouny S, Wilkinson ID, Chong WK, Hall-Craggs MA, Harrison MJ, Gili J, Rovira A, Capellades J, Rio J, Ocana I, Nicoli F, Dhiver C, Gastaut JL, Gastaut JA, Wicklow K, Sauter R. Paley M, et al. Among authors: dhiver c. AIDS Res Hum Retroviruses. 1996 Feb 10;12(3):213-22. doi: 10.1089/aid.1996.12.213. AIDS Res Hum Retroviruses. 1996. PMID: 8835199
Reaching the Second and Third Joint United Nations Programme on HIV/AIDS 90-90-90 Targets Is Accompanied by a Dramatic Reduction in Primary Human Immunodeficiency Virus (HIV) Infection and in Recent HIV Infections in a Large French Nationwide HIV Cohort.
Le Guillou A, Pugliese P, Raffi F, Cabie A, Cuzin L, Katlama C, Allavena C, Drame M, Cotte L, Bani-Sadr F; Dat’AIDS Study Group. Le Guillou A, et al. Clin Infect Dis. 2020 Jul 11;71(2):293-300. doi: 10.1093/cid/ciz800. Clin Infect Dis. 2020. PMID: 31612225
Therapeutic drug monitoring and virological response at week 48 in a cohort of HIV-1-infected patients switching to dolutegravir/rilpivirine dual maintenance therapy (ANRS-MIE-BIRIDER study).
Lemaitre F, Lagoutte-Renosi J, Gagnieu MC, Parant F, Venisse N, Grégoire M, Bouchet S, Garraffo R, Lê MP, Muret P, Comets E, Solas C, Peytavin G; ANRS-MIE-BIRIDER Study group on behalf of the Clinical Pharmacology Group of ANRS-MIE AC43. Lemaitre F, et al. Br J Clin Pharmacol. 2024 Jan;90(1):264-273. doi: 10.1111/bcp.15890. Epub 2023 Sep 18. Br J Clin Pharmacol. 2024. PMID: 37602480 Free article.
Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis.
Lagier JC, Million M, Gautret P, Colson P, Cortaredona S, Giraud-Gatineau A, Honoré S, Gaubert JY, Fournier PE, Tissot-Dupont H, Chabrière E, Stein A, Deharo JC, Fenollar F, Rolain JM, Obadia Y, Jacquier A, La Scola B, Brouqui P, Drancourt M, Parola P, Raoult D; IHU COVID-19 Task force. Lagier JC, et al. Travel Med Infect Dis. 2020 Jul-Aug;36:101791. doi: 10.1016/j.tmaid.2020.101791. Epub 2020 Jun 25. Travel Med Infect Dis. 2020. PMID: 32593867 Free PMC article.
A generalized additive model to disentangle age and diagnosis-specific cohort effects in psychological and behavioral outcomes in people living with HIV: the French cross-sectional ANRS-VESPA2 survey.
Sagaon-Teyssier L, Vilotitch A, Mora M, Maradan G, Guagliardo V, Suzan-Monti M, Dray-Spira R, Spire B; VESPA2 study group. Sagaon-Teyssier L, et al. BMC Public Health. 2019 May 17;19(1):590. doi: 10.1186/s12889-019-6905-z. BMC Public Health. 2019. PMID: 31101129 Free PMC article.
Missed opportunities of HIV pre-exposure prophylaxis in France: a retrospective analysis in the French DAT'AIDS cohort.
Lions C, Cabras O, Cotte L, Huleux T, Gagneux-Brugnon A, Makinson A, Cabié A, Bonnet B, Duvivier C, Hocqueloux L, Cua E, Cheret A, Hustache-Mathieu L, Obry-Roguet V, Jacomet C, Poizot-Martin I; DAT’AIDS STUDY GROUP. Lions C, et al. BMC Infect Dis. 2019 Mar 25;19(1):278. doi: 10.1186/s12879-019-3915-5. BMC Infect Dis. 2019. PMID: 30909885 Free PMC article.
Prevalence of and factors associated with depression among people living with HIV in France.
Feuillet P, Lert F, Tron L, Aubriere C, Spire B, Dray-Spira R; Agence Nationale de Recherche sur le Sida et les Hépatites Virales (ANRS)-VIH: Enquête sur les personnes atteintes (Vespa2) Study Group. Feuillet P, et al. HIV Med. 2017 Jul;18(6):383-394. doi: 10.1111/hiv.12438. Epub 2016 Sep 14. HIV Med. 2017. PMID: 27625202 Free article.
Comparative effectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort study.
Lodi S, Phillips A, Logan R, Olson A, Costagliola D, Abgrall S, van Sighem A, Reiss P, Miró JM, Ferrer E, Justice A, Gandhi N, Bucher HC, Furrer H, Moreno S, Monge S, Touloumi G, Pantazis N, Sterne J, Young JG, Meyer L, Seng R, Dabis F, Vandehende MA, Pérez-Hoyos S, Jarrín I, Jose S, Sabin C, Hernán MA; HIV-CAUSAL Collaboration. Lodi S, et al. Lancet HIV. 2015 Aug;2(8):e335-43. doi: 10.1016/S2352-3018(15)00108-3. Epub 2015 Jul 7. Lancet HIV. 2015. PMID: 26423376 Free PMC article.
104 results